PRELUDE CAPITAL MANAGEMENT, LLC - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.

Links
Filings
External links
Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$8,033,000
+526.1%
233,193
+396.2%
0.39%
+424.3%
Q3 2018$1,283,000–47,000–0.07%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q4 2018.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders